Toboroz
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
NCT07623200· 3. fázis· Incyte Corporation· Forrás
Toboroz
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
NCT07585890· University Medical Center Groningen· Forrás
Toboroz
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
NCT07294170· argenx· Forrás
Fut, nem toboroz
A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar
NCT07160816· Novo Nordisk A/S· Forrás
Fut, nem toboroz
A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy
NCT06821542· 3. fázis· Incyte Corporation· Forrás
Toboroz
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
NCT06697301· 2/3. fázis· Eikon Therapeutics· Forrás
Fut, nem toboroz
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)
NCT06553768· 3. fázis· Mirum Pharmaceuticals, Inc.· Forrás
Toboroz
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
2023-507539-40-00· 2. fázis· NMD Pharma A/S· Forrás
Toboroz
Real World Pediatric Oncology Rehabilitation in Italy ( ReWori )
NCT07368582· Associazione Italiana Ematologia Oncologia Pediatrica· Forrás
Toboroz
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
2023-503699-25-00· 3. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás
Toboroz
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
2023-503697-21-01· 3. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás
Toboroz
MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction)
NCT05974462· 3. fázis· University Hospital, Antwerp· Forrás
Toboroz
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
NCT06414954· 2. fázis· NMD Pharma A/S· Forrás
Toboroz
A multi-center, open-label, phase 2 study of Elranatamab in patients with high-risk smoldering multiple myeloma
2023-505775-70-00· 2. fázis· European Myeloma Network B.V.· Forrás
Toboroz
A study with new methods to monitor newly diagnosed multiple myeloma in participants being treated with a new treatment combination - TAURUS
NCT06189833· 2. fázis· European Myeloma Network B.V.· Forrás
Toboroz
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
NCT06093672· 3. fázis· Italfarmaco· Forrás
Toboroz
Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy In HER2-positive gastric or gastroesophageal cancer patients with persistence of miNImal residual disease in liquid biopsy after pre-operative chemoTherapy and radical surgerY: the TRINITY study
2023-506662-31-00· 2. fázis· Fondazione GONO G.I.· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy
NCT05979311· 3. fázis· ViiV Healthcare· Forrás
Fut, nem toboroz
A Study to Evaluate ABP 206 Compared with OPDIVO® (Nivolumab) in Subjects with Unresectable or Metastatic Melanoma
2023-503288-40-00· 3. fázis· Amgen Inc.· Forrás
Toboroz
Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia
NCT05869279· 1/2. fázis· Fondazione Matilde Tettamanti Menotti De Marchi Onlus· Forrás
Fut, nem toboroz
Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)
NCT06087835· 3. fázis· AstraZeneca· Forrás
Fut, nem toboroz
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations
NCT06101134· 2. fázis· Bristol-Myers Squibb· Forrás
Fut, nem toboroz
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
NCT05671510· 3. fázis· OncoC4, Inc.· Forrás
Toboroz
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
NCT05907057· 3. fázis· Servier Affaires Médicales· Forrás
Fut, nem toboroz
HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation.
NCT05636176· 3. fázis· Novo Nordisk A/S· Forrás
Fut, nem toboroz
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
NCT05757869· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies
NCT05794906· 3. fázis· Bayer· Forrás
Fut, nem toboroz
A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)
NCT05526755· 2. fázis· AstraZeneca· Forrás
Fut, nem toboroz
Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)
NCT05609968· 3. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200· 3. fázis· Anthos Therapeutics, Inc.· Forrás
Fut, nem toboroz
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
NCT05556096· 3. fázis· Alexion Pharmaceuticals, Inc.· Forrás
Toboroz
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
NCT05491200· 4. fázis· Research Maatschap Cardiologen Rotterdam Zuid· Forrás
Fut, nem toboroz
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
NCT05211895· 3. fázis· AstraZeneca· Forrás
Fut, nem toboroz
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
NCT05070858· 3. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921· European Foundation for Study of Chronic Liver Failure· Forrás
Fut, nem toboroz
Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.
NCT04604067· 2. fázis· Swiss Cancer Institute· Forrás
Toboroz
Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure
NCT06884631· Centro Cardiologico Monzino· Forrás
Fut, nem toboroz
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT04557098· 2. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Efficacy Study of Nivolumab Compared to Placebo in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIB/C Melanoma (CheckMate 76K)
2022-502354-14-00· 3. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás
Fut, nem toboroz
Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence
NCT03443856· 2. fázis· European Organisation for Research and Treatment of Cancer - EORTC· Forrás
Fut, nem toboroz
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis
NCT03900429· 3. fázis· Madrigal Pharmaceuticals, Inc.· Forrás
Fut, nem toboroz
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)
NCT03553836· 3. fázis· Merck Sharp & Dohme LLC· Forrás
Fut, nem toboroz
Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
NCT03595592· 3. fázis· Fondazione Michelangelo· Forrás
Toboroz
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
NCT03435796· 2/3. fázis· Celgene· Forrás
Meghívásos bevonás
International Registry of Congenital Portosystemic Shunt (IRCPSS)
NCT06041906· Prof. Valérie Mc Lin· Forrás
Fut, nem toboroz
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
Arrhythmias Detection in a Real World Population
NCT02275637· Fondazione IRCCS Policlinico San Matteo di Pavia· Forrás
Fut, nem toboroz
Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms
NCT01761968· 2. fázis· Italfarmaco· Forrás